A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis

Inclusion Criteria: * Clinical diagnosis of acute bacterial conjunctivitis and exhibit purulent conjunctival discharge and redness in at least one eye. Exclusion Criteria: * Pregnant or nursing females. * Use of any antibiotic within 72 hours of enrollment. * Any disease conditions that could interfere with the safety and efficacy evaluations of the study drug. * Participation in an ophthalmic drug or device research study within 30 days prior to entry into this study.